ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Companion Diagnostic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-14K8500
Home | Market Reports | Health| Health Conditions| Cancer
Global Oncology Companion Diagnostic Market Insights Forecast to 2028
BUY CHAPTERS

Global Oncology Companion Diagnostic Market Research Report 2025

Code: QYRE-Auto-14K8500
Report
July 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agilent Technologies Inc
Illumina Inc
QIAGEN N V
Thermo Fisher Scientific Inc
F Hoffmann La Roche Ltd
ARUP Laboratories
Abbott
Myriad Genetics Inc
BioMérieux SA
Invivoscribe

Oncology Companion Diagnostic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oncology Companion Diagnostic Market

Oncology Companion Diagnostic Market

The global market for Oncology Companion Diagnostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oncology Companion Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Companion Diagnostic.
The Oncology Companion Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Companion Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Companion Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oncology Companion Diagnostic Market Report

Report Metric Details
Report Name Oncology Companion Diagnostic Market
CAGR 5%
Segment by Type
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Immunohistochemistry (IHC)
  • In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
  • Others
Segment by Application
  • Hospital
  • Pathology/Diagnostic Laboratory
  • Academic Medical Center
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott, Myriad Genetics, Inc., bioMérieux SA, Invivoscribe, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncology Companion Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncology Companion Diagnostic Market report?

Ans: The main players in the Oncology Companion Diagnostic Market are Agilent Technologies, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., ARUP Laboratories, Abbott, Myriad Genetics, Inc., bioMérieux SA, Invivoscribe, Inc.

What are the Application segmentation covered in the Oncology Companion Diagnostic Market report?

Ans: The Applications covered in the Oncology Companion Diagnostic Market report are Hospital, Pathology/Diagnostic Laboratory, Academic Medical Center

What are the Type segmentation covered in the Oncology Companion Diagnostic Market report?

Ans: The Types covered in the Oncology Companion Diagnostic Market report are Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Companion Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Next-Generation Sequencing (NGS)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Companion Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pathology/Diagnostic Laboratory
1.3.4 Academic Medical Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Companion Diagnostic Market Perspective (2020-2031)
2.2 Global Oncology Companion Diagnostic Growth Trends by Region
2.2.1 Global Oncology Companion Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Companion Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Oncology Companion Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Oncology Companion Diagnostic Market Dynamics
2.3.1 Oncology Companion Diagnostic Industry Trends
2.3.2 Oncology Companion Diagnostic Market Drivers
2.3.3 Oncology Companion Diagnostic Market Challenges
2.3.4 Oncology Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Companion Diagnostic Players by Revenue
3.1.1 Global Top Oncology Companion Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Oncology Companion Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Companion Diagnostic Revenue
3.4 Global Oncology Companion Diagnostic Market Concentration Ratio
3.4.1 Global Oncology Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Companion Diagnostic Revenue in 2024
3.5 Global Key Players of Oncology Companion Diagnostic Head office and Area Served
3.6 Global Key Players of Oncology Companion Diagnostic, Product and Application
3.7 Global Key Players of Oncology Companion Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Companion Diagnostic Breakdown Data by Type
4.1 Global Oncology Companion Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Oncology Companion Diagnostic Forecasted Market Size by Type (2026-2031)
5 Oncology Companion Diagnostic Breakdown Data by Application
5.1 Global Oncology Companion Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Oncology Companion Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Companion Diagnostic Market Size (2020-2031)
6.2 North America Oncology Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Companion Diagnostic Market Size by Country (2020-2025)
6.4 North America Oncology Companion Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Companion Diagnostic Market Size (2020-2031)
7.2 Europe Oncology Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Companion Diagnostic Market Size by Country (2020-2025)
7.4 Europe Oncology Companion Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Companion Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Oncology Companion Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Companion Diagnostic Market Size (2020-2031)
9.2 Latin America Oncology Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Companion Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Oncology Companion Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Companion Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Oncology Companion Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Oncology Companion Diagnostic Introduction
11.2.4 Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.2.5 Illumina, Inc. Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Details
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Oncology Companion Diagnostic Introduction
11.3.4 Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.3.5 Qiagen N.V. Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Details
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 ARUP Laboratories
11.6.1 ARUP Laboratories Company Details
11.6.2 ARUP Laboratories Business Overview
11.6.3 ARUP Laboratories Oncology Companion Diagnostic Introduction
11.6.4 ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.6.5 ARUP Laboratories Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Oncology Companion Diagnostic Introduction
11.7.4 Abbott Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.7.5 Abbott Recent Development
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Details
11.8.2 Myriad Genetics, Inc. Business Overview
11.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Introduction
11.8.4 Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.8.5 Myriad Genetics, Inc. Recent Development
11.9 bioMérieux SA
11.9.1 bioMérieux SA Company Details
11.9.2 bioMérieux SA Business Overview
11.9.3 bioMérieux SA Oncology Companion Diagnostic Introduction
11.9.4 bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.9.5 bioMérieux SA Recent Development
11.10 Invivoscribe, Inc.
11.10.1 Invivoscribe, Inc. Company Details
11.10.2 Invivoscribe, Inc. Business Overview
11.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Introduction
11.10.4 Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025)
11.10.5 Invivoscribe, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Agilent Technologies Inc
Illumina Inc
QIAGEN N V
Thermo Fisher Scientific Inc
F Hoffmann La Roche Ltd
ARUP Laboratories
Abbott
Myriad Genetics Inc
BioMérieux SA
Invivoscribe
List of Tables
 Table 1. Global Oncology Companion Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polymerase Chain Reaction (PCR)
 Table 3. Key Players of Next-Generation Sequencing (NGS)
 Table 4. Key Players of Immunohistochemistry (IHC)
 Table 5. Key Players of In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
 Table 6. Key Players of Others
 Table 7. Global Oncology Companion Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Oncology Companion Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Oncology Companion Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Oncology Companion Diagnostic Market Share by Region (2020-2025)
 Table 11. Global Oncology Companion Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Oncology Companion Diagnostic Market Share by Region (2026-2031)
 Table 13. Oncology Companion Diagnostic Market Trends
 Table 14. Oncology Companion Diagnostic Market Drivers
 Table 15. Oncology Companion Diagnostic Market Challenges
 Table 16. Oncology Companion Diagnostic Market Restraints
 Table 17. Global Oncology Companion Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Oncology Companion Diagnostic Market Share by Players (2020-2025)
 Table 19. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Companion Diagnostic as of 2024)
 Table 20. Ranking of Global Top Oncology Companion Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Oncology Companion Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Oncology Companion Diagnostic, Headquarters and Area Served
 Table 23. Global Key Players of Oncology Companion Diagnostic, Product and Application
 Table 24. Global Key Players of Oncology Companion Diagnostic, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Oncology Companion Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Oncology Companion Diagnostic Revenue Market Share by Type (2020-2025)
 Table 28. Global Oncology Companion Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Oncology Companion Diagnostic Revenue Market Share by Type (2026-2031)
 Table 30. Global Oncology Companion Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Oncology Companion Diagnostic Revenue Market Share by Application (2020-2025)
 Table 32. Global Oncology Companion Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Oncology Companion Diagnostic Revenue Market Share by Application (2026-2031)
 Table 34. North America Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Oncology Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Oncology Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Oncology Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Oncology Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Oncology Companion Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Oncology Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Oncology Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Agilent Technologies, Inc. Company Details
 Table 50. Agilent Technologies, Inc. Business Overview
 Table 51. Agilent Technologies, Inc. Oncology Companion Diagnostic Product
 Table 52. Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 53. Agilent Technologies, Inc. Recent Development
 Table 54. Illumina, Inc. Company Details
 Table 55. Illumina, Inc. Business Overview
 Table 56. Illumina, Inc. Oncology Companion Diagnostic Product
 Table 57. Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 58. Illumina, Inc. Recent Development
 Table 59. Qiagen N.V. Company Details
 Table 60. Qiagen N.V. Business Overview
 Table 61. Qiagen N.V. Oncology Companion Diagnostic Product
 Table 62. Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 63. Qiagen N.V. Recent Development
 Table 64. Thermo Fisher Scientific Inc. Company Details
 Table 65. Thermo Fisher Scientific Inc. Business Overview
 Table 66. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product
 Table 67. Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 68. Thermo Fisher Scientific Inc. Recent Development
 Table 69. F. Hoffmann-La Roche Ltd. Company Details
 Table 70. F. Hoffmann-La Roche Ltd. Business Overview
 Table 71. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product
 Table 72. F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 73. F. Hoffmann-La Roche Ltd. Recent Development
 Table 74. ARUP Laboratories Company Details
 Table 75. ARUP Laboratories Business Overview
 Table 76. ARUP Laboratories Oncology Companion Diagnostic Product
 Table 77. ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 78. ARUP Laboratories Recent Development
 Table 79. Abbott Company Details
 Table 80. Abbott Business Overview
 Table 81. Abbott Oncology Companion Diagnostic Product
 Table 82. Abbott Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 83. Abbott Recent Development
 Table 84. Myriad Genetics, Inc. Company Details
 Table 85. Myriad Genetics, Inc. Business Overview
 Table 86. Myriad Genetics, Inc. Oncology Companion Diagnostic Product
 Table 87. Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 88. Myriad Genetics, Inc. Recent Development
 Table 89. bioMérieux SA Company Details
 Table 90. bioMérieux SA Business Overview
 Table 91. bioMérieux SA Oncology Companion Diagnostic Product
 Table 92. bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 93. bioMérieux SA Recent Development
 Table 94. Invivoscribe, Inc. Company Details
 Table 95. Invivoscribe, Inc. Business Overview
 Table 96. Invivoscribe, Inc. Oncology Companion Diagnostic Product
 Table 97. Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2020-2025) & (US$ Million)
 Table 98. Invivoscribe, Inc. Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. Oncology Companion Diagnostic Picture
 Figure 2. Global Oncology Companion Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oncology Companion Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Polymerase Chain Reaction (PCR) Features
 Figure 5. Next-Generation Sequencing (NGS) Features
 Figure 6. Immunohistochemistry (IHC) Features
 Figure 7. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) Features
 Figure 8. Others Features
 Figure 9. Global Oncology Companion Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Oncology Companion Diagnostic Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Pathology/Diagnostic Laboratory Case Studies
 Figure 13. Academic Medical Center Case Studies
 Figure 14. Oncology Companion Diagnostic Report Years Considered
 Figure 15. Global Oncology Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Oncology Companion Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Oncology Companion Diagnostic Market Share by Region: 2024 VS 2031
 Figure 18. Global Oncology Companion Diagnostic Market Share by Players in 2024
 Figure 19. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Companion Diagnostic as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Oncology Companion Diagnostic Revenue in 2024
 Figure 21. North America Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Oncology Companion Diagnostic Market Share by Country (2020-2031)
 Figure 23. United States Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Oncology Companion Diagnostic Market Share by Country (2020-2031)
 Figure 27. Germany Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Oncology Companion Diagnostic Market Share by Region (2020-2031)
 Figure 35. China Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Oncology Companion Diagnostic Market Share by Country (2020-2031)
 Figure 43. Mexico Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Oncology Companion Diagnostic Market Share by Country (2020-2031)
 Figure 47. Turkey Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Oncology Companion Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Agilent Technologies, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 51. Illumina, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 52. Qiagen N.V. Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 53. Thermo Fisher Scientific Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 54. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 55. ARUP Laboratories Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 56. Abbott Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 57. Myriad Genetics, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 58. bioMérieux SA Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 59. Invivoscribe, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Companion Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Companion Diagnostic Market Research Report 2024
Digital Companion Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Companion Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Companion Diagnostics Devices Market Research Report 2025
Companion Diagnostics for Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Oncology Testing Market Research Report 2024
Companion Diagnostic Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Based Molecular Diagnostics Market Insights Forecast to 2030
Oncology Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology and Cancer Treatment Drug Market Research Report 2024
Global Personalized Medicines In Oncology Market Research Report 2024
Global Hematology Oncology Diagnostics Market Research Report 2024
Companion Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tumor Marker Testing Market Research Report 2024
Oncology Based Molecular Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Companion Diagnostics CDx Development Services Market Research Report 2024
Global Cancer Diagnostics Service Market Research Report 2025
Global Emerging Cancer Diagnostics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions